{
    "Trade/Device Name(s)": [
        "Albumin BCP"
    ],
    "Submitter Information": "Sentinel CH. S.p.A.",
    "510(k) Number": "K193001",
    "Predicate Device Reference 510(k) Number(s)": [
        "K132664"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CJW"
    ],
    "Summary Letter Date": "October 23, 2019",
    "Summary Letter Received Date": "October 28, 2019",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1035"
    ],
    "Regulation Name(s)": [
        "Albumin test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Albumin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Lithium-Heparin tube",
        "Potassium EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "AU680 Automatic Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Colorimetric",
        "Bromcresol purple dye-binding"
    ],
    "Methodologies": [
        "Colorimetric endpoint reaction"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Sentinel CH. S.p.A. Albumin BCP colorimetric assay for quantifying albumin in serum or plasma using AU680 analyzer.",
    "Indications for Use Summary": "For in vitro diagnostic quantitative measurement of albumin in human serum or plasma to aid diagnosis and treatment of diseases primarily involving the liver or kidneys, intended for professional use only.",
    "fda_folder": "Clinical Chemistry"
}